Back
Opus Genetics 10K Form
Sell
37
IRD
Opus Genetics
Last Price:
1.07
Seasonality Move:
3.61%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive IRD News And Ratings
See the #1 stock for the next 7 days that we like better than IRD
IRD Financial Statistics
Sales & Book Value
| Annual Sales: | $19.05M |
|---|---|
| Cash Flow: | $-7.29M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.56 |
| Price / Book: | 0.73 |
Profitability
| EPS (TTM): | -0.55000 |
|---|---|
| Net Income (TTM): | $-14.11M |
| Gross Margin: | -- |
| Return on Equity: | -31.4% |
| Return on Assets: | -28.41% |
Opus Genetics Earnings Forecast
Key Opus Genetics Financial Ratios
- The Research & Development expenses have been 92.67% of Revenue.
- The Interest Expense is 0.00% of Operating Income.
- The Net Earning history of IRD is -52.42% of Total Revenues.
- Per Share Earnings over the last 4 years have been positive in 2 years.
Opus Genetics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | IRD |
| Website: | opusgtx.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 10.68 |
| Quick Ratio: | 10.41 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
IRD Technical Analysis vs Fundamental Analysis
Sell
37
Opus Genetics (IRD)
is a Sell
Is Opus Genetics a Buy or a Sell?
-
Opus Genetics stock is rated a Sell
The current Opus Genetics [IRD] share price is $1.09. The Score for IRD is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.